Register a trial

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT06034743




Registration number
NCT06034743
Ethics application status
Date submitted
6/09/2023
Date registered
13/09/2023

Titles & IDs
Public title
A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension
Scientific title
A Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension
Secondary ID [1] 0 0
2023-505499-32-00
Secondary ID [2] 0 0
D6970C00002
Universal Trial Number (UTN)
Trial acronym
BaxHTN
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Uncontrolled Hypertension 0 0
Resistant Hypertension 0 0
Condition category
Condition code
Cardiovascular 0 0 0 0
Hypertension

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Drugs - Baxdrostat
Treatment: Drugs - Placebo

Experimental: 2 mg baxdrostat - 2 mg baxdrostat administered orally, once daily (QD).

Experimental: 1 mg baxdrostat - 1 mg baxdrostat administered orally, once daily (QD).

Placebo comparator: Placebo - Placebo administered orally, once daily (QD).


Treatment: Drugs: Baxdrostat
Baxdrostat tablet administered orally, once daily (QD). Unit dose strengths:

* 1 mg per tablet for 1 mg baxdrostat Arm;
* 2 mg per tablet for 2 mg baxdrostat Arm.

Treatment: Drugs: Placebo
Placebo tablet matching baxdrostat, administered orally, once daily (QD).
Intervention code [1] 0 0
Treatment: Drugs
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Change from baseline in seated systolic blood pressure for 2 mg baxdrostat
Timepoint [1] 0 0
At Week 12
Primary outcome [2] 0 0
Change from baseline in seated systolic blood pressure for 1 mg baxdrostat
Timepoint [2] 0 0
At Week 12
Secondary outcome [1] 0 0
Change from randomised withdrawal baseline (Week 24) in seated systolic blood pressure (SBP) for 2 mg baxdrostat
Timepoint [1] 0 0
At Week 32
Secondary outcome [2] 0 0
Change from baseline in seated SBP for 2 mg baxdrostat
Timepoint [2] 0 0
At Week 12
Secondary outcome [3] 0 0
Change from baseline in seated diastolic blood pressure (DBP) for 2 mg baxdrostat
Timepoint [3] 0 0
At Week 12
Secondary outcome [4] 0 0
Achieving seated SBP < 130 mmHg for 2 mg baxdrostat
Timepoint [4] 0 0
At Week 12
Secondary outcome [5] 0 0
Change from baseline in seated SBP for 1 mg baxdrostat
Timepoint [5] 0 0
At Week 12
Secondary outcome [6] 0 0
Change from baseline in seated DBP for 1 mg baxdrostat
Timepoint [6] 0 0
At Week 12
Secondary outcome [7] 0 0
Achieving seated SBP < 130 mmHg for 1 mg baxdrostat
Timepoint [7] 0 0
At Week 12

Eligibility
Key inclusion criteria
* Male or female participants must be = 18 years old
* Mean sitting systolic blood pressure on automated office blood pressure measurement = 140 mmHg and < 170 mmHg at Screening
* Fulfil at least 1 of the following 2 criteria:

1. uHTN subpopulation: have a stable regimen of 2 antihypertensive medications, from different therapeutic classes (at least one must be a diuretic), at maximum tolerated dose in the judgement of the Investigator
2. rHTN subpopulation: have a stable regimen of = 3 antihypertensive medications, from different therapeutic classes (at least one must be a diuretic), at maximum tolerated dose in the judgement of the Investigator
* Estimated glomerular filtration rate = 45 mL/min/1.73m2 at Screening
* Serum potassium (K+) level = 3.5 and < 5.0 mmol/L at Screening
* Randomisation Criterion:
* Sitting systolic blood pressure on attended automated office blood pressure measurement of = 135 mmHg at the Baseline Visit
Minimum age
18 Years
Maximum age
130 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Mean sitting systolic blood pressure on attended automated office blood pressure measurement = 170 mmHg
* Mean seated diastolic blood pressure on attended automated office blood pressure measurement = 110 mmHg
* Serum sodium level < 135 mmol/L at Screening
* Has the following known secondary causes of hypertension: renal artery stenosis, uncontrolled or untreated hyperthyroidism, uncontrolled or untreated hypothyroidism, pheochromocytoma, Cushing's syndrome, aortic coarctation
* New York Heart Association functional heart failure class IV at Screening
* Persistent atrial fibrillation

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Phase 3
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
22/11/2023
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
13/10/2025
Actual
Sample size
Target
720
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
Recruitment hospital [1] 0 0
Research Site - Clayton
Recruitment hospital [2] 0 0
Research Site - Darlinghurst
Recruitment hospital [3] 0 0
Research Site - Epping
Recruitment hospital [4] 0 0
Research Site - Geelong
Recruitment hospital [5] 0 0
Research Site - Liverpool
Recruitment hospital [6] 0 0
Research Site - New Lambton Heights
Recruitment hospital [7] 0 0
Research Site - Perth
Recruitment hospital [8] 0 0
Research Site - Wollongong
Recruitment hospital [9] 0 0
Research Site - Woolloongabba
Recruitment postcode(s) [1] 0 0
3168 - Clayton
Recruitment postcode(s) [2] 0 0
2010 - Darlinghurst
Recruitment postcode(s) [3] 0 0
3076 - Epping
Recruitment postcode(s) [4] 0 0
3220 - Geelong
Recruitment postcode(s) [5] 0 0
2170 - Liverpool
Recruitment postcode(s) [6] 0 0
2305 - New Lambton Heights
Recruitment postcode(s) [7] 0 0
6000 - Perth
Recruitment postcode(s) [8] 0 0
2500 - Wollongong
Recruitment postcode(s) [9] 0 0
4102 - Woolloongabba
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Alabama
Country [2] 0 0
United States of America
State/province [2] 0 0
Arizona
Country [3] 0 0
United States of America
State/province [3] 0 0
Arkansas
Country [4] 0 0
United States of America
State/province [4] 0 0
California
Country [5] 0 0
United States of America
State/province [5] 0 0
Connecticut
Country [6] 0 0
United States of America
State/province [6] 0 0
Florida
Country [7] 0 0
United States of America
State/province [7] 0 0
Georgia
Country [8] 0 0
United States of America
State/province [8] 0 0
Illinois
Country [9] 0 0
United States of America
State/province [9] 0 0
Indiana
Country [10] 0 0
United States of America
State/province [10] 0 0
Kentucky
Country [11] 0 0
United States of America
State/province [11] 0 0
Massachusetts
Country [12] 0 0
United States of America
State/province [12] 0 0
Michigan
Country [13] 0 0
United States of America
State/province [13] 0 0
Minnesota
Country [14] 0 0
United States of America
State/province [14] 0 0
Mississippi
Country [15] 0 0
United States of America
State/province [15] 0 0
Missouri
Country [16] 0 0
United States of America
State/province [16] 0 0
New York
Country [17] 0 0
United States of America
State/province [17] 0 0
North Carolina
Country [18] 0 0
United States of America
State/province [18] 0 0
Ohio
Country [19] 0 0
United States of America
State/province [19] 0 0
Oregon
Country [20] 0 0
United States of America
State/province [20] 0 0
Pennsylvania
Country [21] 0 0
United States of America
State/province [21] 0 0
Rhode Island
Country [22] 0 0
United States of America
State/province [22] 0 0
Tennessee
Country [23] 0 0
United States of America
State/province [23] 0 0
Texas
Country [24] 0 0
United States of America
State/province [24] 0 0
Virginia
Country [25] 0 0
United States of America
State/province [25] 0 0
Wisconsin
Country [26] 0 0
Argentina
State/province [26] 0 0
Buenos Aires
Country [27] 0 0
Argentina
State/province [27] 0 0
Caba
Country [28] 0 0
Argentina
State/province [28] 0 0
Cordoba
Country [29] 0 0
Argentina
State/province [29] 0 0
Córdoba
Country [30] 0 0
Argentina
State/province [30] 0 0
Mar del Plata
Country [31] 0 0
Argentina
State/province [31] 0 0
Mendoza
Country [32] 0 0
Argentina
State/province [32] 0 0
Rosario
Country [33] 0 0
Argentina
State/province [33] 0 0
San Miguel de Tucuman
Country [34] 0 0
Argentina
State/province [34] 0 0
San Nicolás
Country [35] 0 0
Argentina
State/province [35] 0 0
San Vicente
Country [36] 0 0
Austria
State/province [36] 0 0
Braunau am Inn
Country [37] 0 0
Austria
State/province [37] 0 0
St. Pölten
Country [38] 0 0
Austria
State/province [38] 0 0
Wien
Country [39] 0 0
Belgium
State/province [39] 0 0
Aalst
Country [40] 0 0
Belgium
State/province [40] 0 0
Genk
Country [41] 0 0
Belgium
State/province [41] 0 0
Gent
Country [42] 0 0
Belgium
State/province [42] 0 0
Leuven
Country [43] 0 0
Belgium
State/province [43] 0 0
Liège
Country [44] 0 0
Belgium
State/province [44] 0 0
Mons
Country [45] 0 0
Bulgaria
State/province [45] 0 0
Pleven
Country [46] 0 0
Bulgaria
State/province [46] 0 0
Sofia
Country [47] 0 0
Canada
State/province [47] 0 0
Alberta
Country [48] 0 0
Canada
State/province [48] 0 0
British Columbia
Country [49] 0 0
Canada
State/province [49] 0 0
Ontario
Country [50] 0 0
Canada
State/province [50] 0 0
Quebec
Country [51] 0 0
Czechia
State/province [51] 0 0
Benesov
Country [52] 0 0
Czechia
State/province [52] 0 0
Brandys nad Labem
Country [53] 0 0
Czechia
State/province [53] 0 0
Broumov
Country [54] 0 0
Czechia
State/province [54] 0 0
Louny
Country [55] 0 0
Czechia
State/province [55] 0 0
Ostrava
Country [56] 0 0
Czechia
State/province [56] 0 0
Pribram
Country [57] 0 0
Czechia
State/province [57] 0 0
Uherske Hradiste
Country [58] 0 0
Denmark
State/province [58] 0 0
Aarhus
Country [59] 0 0
Denmark
State/province [59] 0 0
Herning
Country [60] 0 0
Denmark
State/province [60] 0 0
Holbæk
Country [61] 0 0
France
State/province [61] 0 0
Bobigny
Country [62] 0 0
France
State/province [62] 0 0
Bordeaux
Country [63] 0 0
France
State/province [63] 0 0
Lille
Country [64] 0 0
France
State/province [64] 0 0
Paris Cedex 14
Country [65] 0 0
France
State/province [65] 0 0
Paris
Country [66] 0 0
France
State/province [66] 0 0
Poitiers
Country [67] 0 0
France
State/province [67] 0 0
Saint-Priest-en-Jarez
Country [68] 0 0
France
State/province [68] 0 0
Toulon
Country [69] 0 0
France
State/province [69] 0 0
Toulouse
Country [70] 0 0
France
State/province [70] 0 0
Tours CEDEX
Country [71] 0 0
Germany
State/province [71] 0 0
Bad Homburg
Country [72] 0 0
Germany
State/province [72] 0 0
Bad Oeynhausen
Country [73] 0 0
Germany
State/province [73] 0 0
Berlin
Country [74] 0 0
Germany
State/province [74] 0 0
Dortmund
Country [75] 0 0
Germany
State/province [75] 0 0
Düsseldorf
Country [76] 0 0
Germany
State/province [76] 0 0
Elsterwerda
Country [77] 0 0
Germany
State/province [77] 0 0
Erfurt
Country [78] 0 0
Germany
State/province [78] 0 0
Erlangen
Country [79] 0 0
Germany
State/province [79] 0 0
Essen
Country [80] 0 0
Germany
State/province [80] 0 0
Frankfurt am Main
Country [81] 0 0
Germany
State/province [81] 0 0
Frankfurt
Country [82] 0 0
Germany
State/province [82] 0 0
Hannover
Country [83] 0 0
Germany
State/province [83] 0 0
Homburg
Country [84] 0 0
Germany
State/province [84] 0 0
Kaiserslautern
Country [85] 0 0
Germany
State/province [85] 0 0
Leipzig
Country [86] 0 0
Germany
State/province [86] 0 0
Lübeck
Country [87] 0 0
Germany
State/province [87] 0 0
Mainz
Country [88] 0 0
Germany
State/province [88] 0 0
Mannheim
Country [89] 0 0
Germany
State/province [89] 0 0
Marburg
Country [90] 0 0
Germany
State/province [90] 0 0
Regensburg
Country [91] 0 0
Germany
State/province [91] 0 0
Wermsdorf
Country [92] 0 0
Hungary
State/province [92] 0 0
Balatonfüred
Country [93] 0 0
Hungary
State/province [93] 0 0
Budapest
Country [94] 0 0
Hungary
State/province [94] 0 0
Kalocsa
Country [95] 0 0
Hungary
State/province [95] 0 0
Kaposvár
Country [96] 0 0
Hungary
State/province [96] 0 0
Nyíregyháza
Country [97] 0 0
Hungary
State/province [97] 0 0
Pécs
Country [98] 0 0
Hungary
State/province [98] 0 0
Szeged
Country [99] 0 0
India
State/province [99] 0 0
Delhi
Country [100] 0 0
India
State/province [100] 0 0
Guntur
Country [101] 0 0
India
State/province [101] 0 0
Hyderabad
Country [102] 0 0
India
State/province [102] 0 0
Jaipur
Country [103] 0 0
India
State/province [103] 0 0
Kanpur
Country [104] 0 0
India
State/province [104] 0 0
Kolkata
Country [105] 0 0
India
State/province [105] 0 0
Manipal
Country [106] 0 0
India
State/province [106] 0 0
Mysuru
Country [107] 0 0
India
State/province [107] 0 0
New Delhi
Country [108] 0 0
India
State/province [108] 0 0
Puducherry
Country [109] 0 0
India
State/province [109] 0 0
Pune
Country [110] 0 0
India
State/province [110] 0 0
Surat
Country [111] 0 0
Israel
State/province [111] 0 0
Ashdod
Country [112] 0 0
Israel
State/province [112] 0 0
Haifa
Country [113] 0 0
Israel
State/province [113] 0 0
petach Tikva
Country [114] 0 0
Israel
State/province [114] 0 0
Ramat Gan
Country [115] 0 0
Israel
State/province [115] 0 0
Rehovot
Country [116] 0 0
Italy
State/province [116] 0 0
Acquaviva delle Fonti
Country [117] 0 0
Italy
State/province [117] 0 0
Bologna
Country [118] 0 0
Italy
State/province [118] 0 0
Brescia
Country [119] 0 0
Italy
State/province [119] 0 0
Milano
Country [120] 0 0
Italy
State/province [120] 0 0
Pisa
Country [121] 0 0
Italy
State/province [121] 0 0
Roma
Country [122] 0 0
Italy
State/province [122] 0 0
Torino
Country [123] 0 0
Italy
State/province [123] 0 0
Udine
Country [124] 0 0
Japan
State/province [124] 0 0
Adachi-ku
Country [125] 0 0
Japan
State/province [125] 0 0
Chuo-ku
Country [126] 0 0
Japan
State/province [126] 0 0
Kanazawa-shi
Country [127] 0 0
Japan
State/province [127] 0 0
Koga-shi
Country [128] 0 0
Japan
State/province [128] 0 0
Kyoto-shi
Country [129] 0 0
Japan
State/province [129] 0 0
Nagasaki-shi
Country [130] 0 0
Japan
State/province [130] 0 0
Okayama-shi
Country [131] 0 0
Japan
State/province [131] 0 0
Osaka-shi
Country [132] 0 0
Japan
State/province [132] 0 0
Sapporo-shi
Country [133] 0 0
Japan
State/province [133] 0 0
Tsuchiura-shi
Country [134] 0 0
Japan
State/province [134] 0 0
Yufu-shi
Country [135] 0 0
Korea, Republic of
State/province [135] 0 0
Bucheon-si
Country [136] 0 0
Korea, Republic of
State/province [136] 0 0
Busan
Country [137] 0 0
Korea, Republic of
State/province [137] 0 0
Daejeon
Country [138] 0 0
Korea, Republic of
State/province [138] 0 0
Incheon
Country [139] 0 0
Korea, Republic of
State/province [139] 0 0
Seoul
Country [140] 0 0
Malaysia
State/province [140] 0 0
Kajang
Country [141] 0 0
Malaysia
State/province [141] 0 0
Kota Bharu
Country [142] 0 0
Malaysia
State/province [142] 0 0
Kuching
Country [143] 0 0
Malaysia
State/province [143] 0 0
Melaka
Country [144] 0 0
Malaysia
State/province [144] 0 0
Muar
Country [145] 0 0
Malaysia
State/province [145] 0 0
Sarawak Miri
Country [146] 0 0
Malaysia
State/province [146] 0 0
Seri Manjung
Country [147] 0 0
Netherlands
State/province [147] 0 0
Amsterdam
Country [148] 0 0
Netherlands
State/province [148] 0 0
Hoogeveen
Country [149] 0 0
Netherlands
State/province [149] 0 0
Nijmegen
Country [150] 0 0
Netherlands
State/province [150] 0 0
Utrecht
Country [151] 0 0
Poland
State/province [151] 0 0
Bialystok
Country [152] 0 0
Poland
State/province [152] 0 0
Bydgoszcz
Country [153] 0 0
Poland
State/province [153] 0 0
Chrzanów
Country [154] 0 0
Poland
State/province [154] 0 0
Gdansk
Country [155] 0 0
Poland
State/province [155] 0 0
Gdynia
Country [156] 0 0
Poland
State/province [156] 0 0
Kraków
Country [157] 0 0
Poland
State/province [157] 0 0
Lodz
Country [158] 0 0
Poland
State/province [158] 0 0
Poznan
Country [159] 0 0
Poland
State/province [159] 0 0
Warszawa
Country [160] 0 0
Slovakia
State/province [160] 0 0
Bratislava
Country [161] 0 0
Slovakia
State/province [161] 0 0
Brezno
Country [162] 0 0
Slovakia
State/province [162] 0 0
Kosice
Country [163] 0 0
Slovakia
State/province [163] 0 0
Moldava nad Bodvou
Country [164] 0 0
Slovakia
State/province [164] 0 0
Presov
Country [165] 0 0
Slovakia
State/province [165] 0 0
Rimavska Sobota
Country [166] 0 0
Slovakia
State/province [166] 0 0
Svidník
Country [167] 0 0
Slovakia
State/province [167] 0 0
Trnava
Country [168] 0 0
South Africa
State/province [168] 0 0
Cape Town
Country [169] 0 0
South Africa
State/province [169] 0 0
Centurion
Country [170] 0 0
South Africa
State/province [170] 0 0
Claremont
Country [171] 0 0
South Africa
State/province [171] 0 0
Durban
Country [172] 0 0
South Africa
State/province [172] 0 0
Kwadwesi
Country [173] 0 0
South Africa
State/province [173] 0 0
Somerset West
Country [174] 0 0
South Africa
State/province [174] 0 0
Worcester
Country [175] 0 0
Spain
State/province [175] 0 0
Barcelona
Country [176] 0 0
Spain
State/province [176] 0 0
Ferrol
Country [177] 0 0
Spain
State/province [177] 0 0
Granada
Country [178] 0 0
Spain
State/province [178] 0 0
Madrid
Country [179] 0 0
Spain
State/province [179] 0 0
Majadahonda
Country [180] 0 0
Spain
State/province [180] 0 0
Oviedo
Country [181] 0 0
Spain
State/province [181] 0 0
Sevilla
Country [182] 0 0
Spain
State/province [182] 0 0
Terrassa (Barcelona)
Country [183] 0 0
Sweden
State/province [183] 0 0
Göteborg
Country [184] 0 0
Sweden
State/province [184] 0 0
Stockholm
Country [185] 0 0
Sweden
State/province [185] 0 0
Uppsala
Country [186] 0 0
Taiwan
State/province [186] 0 0
Kaohsiung
Country [187] 0 0
Taiwan
State/province [187] 0 0
Taichung
Country [188] 0 0
Taiwan
State/province [188] 0 0
Taipei City
Country [189] 0 0
Taiwan
State/province [189] 0 0
Taipei
Country [190] 0 0
Taiwan
State/province [190] 0 0
Yung Kang City
Country [191] 0 0
Thailand
State/province [191] 0 0
Bangkok
Country [192] 0 0
Thailand
State/province [192] 0 0
Chiang Mai
Country [193] 0 0
Thailand
State/province [193] 0 0
Hat Yai
Country [194] 0 0
Thailand
State/province [194] 0 0
Muang
Country [195] 0 0
Thailand
State/province [195] 0 0
Pathumthani
Country [196] 0 0
Turkey
State/province [196] 0 0
Adana
Country [197] 0 0
Turkey
State/province [197] 0 0
Ankara
Country [198] 0 0
Turkey
State/province [198] 0 0
Bursa
Country [199] 0 0
Turkey
State/province [199] 0 0
Dinar
Country [200] 0 0
Turkey
State/province [200] 0 0
Istanbul
Country [201] 0 0
Turkey
State/province [201] 0 0
Izmir
Country [202] 0 0
Turkey
State/province [202] 0 0
Kütahya
Country [203] 0 0
Turkey
State/province [203] 0 0
Odunpazari
Country [204] 0 0
United Kingdom
State/province [204] 0 0
Bollington
Country [205] 0 0
United Kingdom
State/province [205] 0 0
Bristol
Country [206] 0 0
United Kingdom
State/province [206] 0 0
Chesterfield
Country [207] 0 0
United Kingdom
State/province [207] 0 0
Dundee
Country [208] 0 0
United Kingdom
State/province [208] 0 0
Glasgow
Country [209] 0 0
United Kingdom
State/province [209] 0 0
Harrow
Country [210] 0 0
United Kingdom
State/province [210] 0 0
Hownslow
Country [211] 0 0
United Kingdom
State/province [211] 0 0
London
Country [212] 0 0
United Kingdom
State/province [212] 0 0
Prescot
Country [213] 0 0
United Kingdom
State/province [213] 0 0
Stockport
Country [214] 0 0
United Kingdom
State/province [214] 0 0
Weston-Super-Mare
Country [215] 0 0
United Kingdom
State/province [215] 0 0
Yate
Country [216] 0 0
Vietnam
State/province [216] 0 0
Da Nang
Country [217] 0 0
Vietnam
State/province [217] 0 0
Ha Noi
Country [218] 0 0
Vietnam
State/province [218] 0 0
Hanoi
Country [219] 0 0
Vietnam
State/province [219] 0 0
Ho Chi Minh
Country [220] 0 0
Vietnam
State/province [220] 0 0
Hochiminh city

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
AstraZeneca
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
AstraZeneca Clinical Study Information Center
Address 0 0
Country 0 0
Phone 0 0
1-877-240-9479
Fax 0 0
Email 0 0
information.center@astrazeneca.com
Contact person for scientific queries

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Yes
What data in particular will be shared?
Qualified researchers can request access to anonymized individual patient-level data from AstraZeneca group of companies sponsored clinical trials via the request portal Vivli.org. All requests will be evaluated as per the AZ disclosure commitment:

https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.

"Yes", indicates that AZ are accepting requests for IPD, but this does not mean all requests will be approved.

Supporting document/s available: Study protocol, Statistical analysis plan (SAP)
When will data be available (start and end dates)?
AstraZeneca will meet or exceed data availability as per the commitments made to the EFPIA/PhRMA Data-Sharing Principles. For details of our timelines, please refer to our disclosure commitment at:

https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.
Available to whom?
When a request has been approved AstraZeneca will provide access to the anonymized individual patient-level data via secure research environment Vivli.org. A Signed Data Usage Agreement (non-negotiable contract for data accessors) must be in place before accessing requested information.
Available for what types of analyses?
How or where can data be obtained?
IPD available at link: https://vivli.org/


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.


Results not provided in https://clinicaltrials.gov/study/NCT06034743